Literature DB >> 10751575

Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons.

K Shinpo1, S Kikuchi, H Sasaki, A Ogata, F Moriwaka, K Tashiro.   

Abstract

We investigated the effects of two reactive dicarbonyl compounds, methylglyoxal (MG) and 3-deoxyglucosone (3-DG), on cultured spinal cord neurons. Incubation of cortical and spinal neurons with MG and 3-DG for 24 h induced neuronal death in a dose-dependent manner. Spinal motor neurons were more vulnerable than spinal non-motor neurons and cortical neurons. Treatments with glutathione (GSH)-augmenting agents showed protective effects against MG and 3-DG neurotoxicity. Motor neurons were better protected than non-motor neurons. Cotreatment, but not pretreatment, of aminoguanidine (AG), a known inhibitor of advanced glycation end-products (AGEs) from crosslinking, showed a protective effect on spinal neurons with no difference in protective rates between motor and non-motor spinal neurons. Treatments with GSH depleting agents enhanced the neurotoxicity of MG and 3-DG on spinal neurons. Motor neurons were more vulnerable than non-motor neurons with GSH-depleting treatments prior to MG and 3-DG exposures. These data demonstrate that spinal motor neurons are more vulnerable to dicarbonyl compounds, and this selectivity might be related to the relatively inefficient GSH system in spinal motor neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751575     DOI: 10.1016/s0006-8993(00)02047-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Gclc deficiency in mouse CNS causes mitochondrial damage and neurodegeneration.

Authors:  Weiyi Feng; Mariana Rosca; Yuxuan Fan; Yufen Hu; Pingfu Feng; Hyoung-Gon Lee; Vincent M Monnier; Xingjun Fan
Journal:  Hum Mol Genet       Date:  2017-04-01       Impact factor: 6.150

2.  GLO1 gene polymorphisms and their association with retinitis pigmentosa: a case-control study in a Sicilian population.

Authors:  Luigi Donato; Concetta Scimone; Giacomo Nicocia; Lucia Denaro; Renato Robledo; Antonina Sidoti; Rosalia D'Angelo
Journal:  Mol Biol Rep       Date:  2018-08-11       Impact factor: 2.316

3.  The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal.

Authors:  Julie Webster; Christin Urban; Katrin Berbaum; Claudia Loske; Alan Alpar; Ulrich Gärtner; Susana Garcia de Arriba; Thomas Arendt; Gerald Münch
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

4.  Effects of methylglyoxal and pyridoxamine in rat brain mitochondria bioenergetics and oxidative status.

Authors:  Susana Cardoso; Cristina Carvalho; Ricardo Marinho; Anabel Simões; Cristina M Sena; Paulo Matafome; Maria S Santos; Raquel M Seiça; Paula I Moreira
Journal:  J Bioenerg Biomembr       Date:  2014-05-17       Impact factor: 2.945

5.  Arg354 in the catalytic centre of bovine liver catalase is protected from methylglyoxal-mediated glycation.

Authors:  Christian Q Scheckhuber
Journal:  BMC Res Notes       Date:  2015-12-30

6.  High throughput assay for evaluation of reactive carbonyl scavenging capacity.

Authors:  N Vidal; J P Cavaille; F Graziani; M Robin; O Ouari; S Pietri; P Stocker
Journal:  Redox Biol       Date:  2014-01-30       Impact factor: 11.799

7.  The Antioxidant, Anti-Inflammatory, and Neuroprotective Properties of the Synthetic Chalcone Derivative AN07.

Authors:  Yih-Fung Chen; Sheng-Nan Wu; Jia-Mao Gao; Zhi-Yao Liao; Yu-Ting Tseng; Ferenc Fülöp; Fang-Rong Chang; Yi-Ching Lo
Journal:  Molecules       Date:  2020-06-24       Impact factor: 4.411

Review 8.  The untwining of immunosenescence and aging.

Authors:  Weili Xu; Glenn Wong; You Yi Hwang; Anis Larbi
Journal:  Semin Immunopathol       Date:  2020-11-09       Impact factor: 9.623

Review 9.  Role of methylglyoxal in Alzheimer's disease.

Authors:  Cristina Angeloni; Laura Zambonin; Silvana Hrelia
Journal:  Biomed Res Int       Date:  2014-03-09       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.